Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
SANG vs LPSN vs NICE vs FIVN vs TWLO
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Software - Application
Software - Infrastructure
Internet Content & Information
SANG vs LPSN vs NICE vs FIVN vs TWLO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Application | Software - Application | Software - Infrastructure | Internet Content & Information |
| Market Cap | $139M | $32M | $5.78B | $1.70B | $29.86B |
| Revenue (TTM) | $307M | $244M | $2.95B | $1.17B | $5.30B |
| Net Income (TTM) | $-8M | $-67M | $612M | $57M | $104M |
| Gross Margin | 52.8% | 62.2% | 66.4% | 55.1% | 48.8% |
| Operating Margin | -1.3% | -9.6% | 21.9% | 4.7% | 4.7% |
| Forward P/E | — | — | 8.7x | 7.0x | 36.3x |
| Total Debt | $56M | $392M | $164M | $847M | $1.08B |
| Cash & Equiv. | $13M | $95M | $379M | $232M | $682M |
SANG vs LPSN vs NICE vs FIVN vs TWLO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Sangoma Technologie… (SANG) | 100 | 291.0 | +191.0% |
| LivePerson, Inc. (LPSN) | 100 | 0.5 | -99.5% |
| NICE Ltd. (NICE) | 100 | 51.4 | -48.6% |
| Five9, Inc. (FIVN) | 100 | 21.3 | -78.7% |
| Twilio Inc. (TWLO) | 100 | 99.7 | -0.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SANG vs LPSN vs NICE vs FIVN vs TWLO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SANG ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 4 yrs, beta 0.16
- 20.0% 10Y total return vs TWLO's 5.8%
- Beta 0.16 vs LPSN's 2.05
Among these 5 stocks, LPSN doesn't own a clear edge in any measured category.
NICE has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and defensive.
- Lower volatility, beta 0.72, Low D/E 4.2%, current ratio 1.55x
- Beta 0.72, current ratio 1.55x
- 20.8% margin vs LPSN's -27.6%
- 11.8% ROA vs LPSN's -12.4%, ROIC 13.2% vs -6.6%
FIVN is the clearest fit if your priority is growth exposure.
- Rev growth 10.3%, EPS growth 370.6%, 3Y rev CAGR 13.8%
- Lower P/E (7.0x vs 36.3x)
TWLO is the #2 pick in this set and the best alternative if growth and momentum is your priority.
- 13.7% revenue growth vs LPSN's -22.0%
- +90.3% vs LPSN's -77.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.7% revenue growth vs LPSN's -22.0% | |
| Value | Lower P/E (7.0x vs 36.3x) | |
| Quality / Margins | 20.8% margin vs LPSN's -27.6% | |
| Stability / Safety | Beta 0.16 vs LPSN's 2.05 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +90.3% vs LPSN's -77.1% | |
| Efficiency (ROA) | 11.8% ROA vs LPSN's -12.4%, ROIC 13.2% vs -6.6% |
SANG vs LPSN vs NICE vs FIVN vs TWLO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SANG vs LPSN vs NICE vs FIVN vs TWLO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NICE leads in 2 of 6 categories
SANG leads 2 • TWLO leads 1 • LPSN leads 0 • FIVN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NICE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TWLO is the larger business by revenue, generating $5.3B annually — 21.8x LPSN's $244M. NICE is the more profitable business, keeping 20.8% of every revenue dollar as net income compared to LPSN's -27.6%. On growth, TWLO holds the edge at +20.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $307M | $244M | $2.9B | $1.2B | $5.3B |
| EBITDAEarnings before interest/tax | $57M | -$562,000 | $845M | $140M | $415M |
| Net IncomeAfter-tax profit | -$8M | -$67M | $612M | $57M | $104M |
| Free Cash FlowCash after capex | $43M | -$43M | $665M | $206M | $1.0B |
| Gross MarginGross profit ÷ Revenue | +52.8% | +62.2% | +66.4% | +55.1% | +48.8% |
| Operating MarginEBIT ÷ Revenue | -1.3% | -9.6% | +21.9% | +4.7% | +4.7% |
| Net MarginNet income ÷ Revenue | -2.5% | -27.6% | +20.8% | +4.9% | +2.0% |
| FCF MarginFCF ÷ Revenue | +14.0% | -17.4% | +22.6% | +17.6% | +19.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -13.2% | -19.0% | +9.0% | +9.2% | +20.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -6.7% | +79.4% | +56.5% | +20.0% | +3.8% |
Valuation Metrics
SANG leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 9.9x trailing earnings, NICE trades at a 99% valuation discount to TWLO's 938.4x P/E. On an enterprise value basis, SANG's 3.0x EV/EBITDA is more attractive than TWLO's 77.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $139M | $32M | $5.8B | $1.7B | $29.9B |
| Enterprise ValueMkt cap + debt − cash | $182M | $329M | $5.6B | $2.3B | $30.3B |
| Trailing P/EPrice ÷ TTM EPS | -19.99x | -0.22x | 9.89x | 48.26x | 938.43x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 8.74x | 6.96x | 36.33x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.37x | — | — |
| EV / EBITDAEnterprise value multiple | 2.96x | — | 6.59x | 16.84x | 77.16x |
| Price / SalesMarket cap ÷ Revenue | 0.42x | 0.13x | 1.96x | 1.48x | 5.89x |
| Price / BookPrice ÷ Book value/share | 0.55x | — | 1.56x | 2.46x | 4.03x |
| Price / FCFMarket cap ÷ FCF | 4.22x | — | 8.22x | 8.45x | 28.91x |
Profitability & Efficiency
NICE leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NICE delivers a 16.4% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-3 for SANG. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to FIVN's 1.08x. On the Piotroski fundamental quality scale (0–9), FIVN scores 8/9 vs LPSN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.0% | — | +16.4% | +7.4% | +1.3% |
| ROA (TTM)Return on assets | -2.2% | -12.4% | +11.8% | +3.2% | +1.1% |
| ROICReturn on invested capital | -0.4% | -6.6% | +13.2% | +1.7% | +1.6% |
| ROCEReturn on capital employed | -0.6% | -5.8% | +16.1% | +2.2% | +1.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 7 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.22x | — | 0.04x | 1.08x | 0.14x |
| Net DebtTotal debt minus cash | $43M | $297M | -$216M | $615M | $399M |
| Cash & Equiv.Liquid assets | $13M | $95M | $379M | $232M | $682M |
| Total DebtShort + long-term debt | $56M | $392M | $164M | $847M | $1.1B |
| Interest CoverageEBIT ÷ Interest expense | -1.29x | 0.20x | — | 7.94x | — |
Total Returns (Dividends Reinvested)
TWLO leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SANG five years ago would be worth $12,507 today (with dividends reinvested), compared to $35 for LPSN. Over the past 12 months, TWLO leads with a +90.3% total return vs LPSN's -77.1%. The 3-year compound annual growth rate (CAGR) favors TWLO at 53.2% vs LPSN's -65.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -15.9% | -31.1% | -14.6% | +18.0% | +42.4% |
| 1-Year ReturnPast 12 months | -27.5% | -77.1% | -40.4% | -11.9% | +90.3% |
| 3-Year ReturnCumulative with dividends | +17.0% | -95.8% | -49.3% | -61.4% | +259.4% |
| 5-Year ReturnCumulative with dividends | +25.1% | -99.7% | -59.1% | -87.0% | -35.8% |
| 10-Year ReturnCumulative with dividends | +1995.0% | -97.0% | +50.7% | +125.4% | +584.5% |
| CAGR (3Y)Annualised 3-year return | +5.4% | -65.4% | -20.2% | -27.2% | +53.2% |
Risk & Volatility
Evenly matched — SANG and TWLO each lead in 1 of 2 comparable metrics.
Risk & Volatility
SANG is the less volatile stock with a 0.16 beta — it tends to amplify market swings less than LPSN's 2.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TWLO currently trades 97.9% from its 52-week high vs LPSN's 12.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.16x | 2.05x | 0.72x | 1.79x | 1.51x |
| 52-Week HighHighest price in past year | $6.49 | $21.60 | $180.61 | $30.38 | $201.39 |
| 52-Week LowLowest price in past year | $3.63 | $2.37 | $94.89 | $13.29 | $91.84 |
| % of 52W HighCurrent price vs 52-week peak | +64.6% | +12.4% | +53.0% | +73.1% | +97.9% |
| RSI (14)Momentum oscillator 0–100 | 52.2 | 40.3 | 40.9 | 68.1 | 78.4 |
| Avg Volume (50D)Average daily shares traded | 4K | 148K | 631K | 2.8M | 2.2M |
Analyst Outlook
SANG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: SANG as "Buy", NICE as "Buy", FIVN as "Buy", TWLO as "Buy". Consensus price targets imply 57.8% upside for NICE (target: $151) vs -6.0% for TWLO (target: $185).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $150.88 | $28.40 | $185.17 |
| # AnalystsCovering analysts | 1 | — | 23 | 41 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | 4 | — | 0 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | 0.0% | +8.5% | +2.9% | +2.9% |
NICE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SANG leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
SANG vs LPSN vs NICE vs FIVN vs TWLO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SANG or LPSN or NICE or FIVN or TWLO a better buy right now?
For growth investors, Twilio Inc.
(TWLO) is the stronger pick with 13. 7% revenue growth year-over-year, versus -22. 0% for LivePerson, Inc. (LPSN). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Sangoma Technologies Corporation (SANG) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SANG or LPSN or NICE or FIVN or TWLO?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 9x versus Twilio Inc. at 938. 4x. On forward P/E, Five9, Inc. is actually cheaper at 7. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SANG or LPSN or NICE or FIVN or TWLO?
Over the past 5 years, Sangoma Technologies Corporation (SANG) delivered a total return of +25.
1%, compared to -99. 7% for LivePerson, Inc. (LPSN). Over 10 years, the gap is even starker: SANG returned +1995% versus LPSN's -97. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SANG or LPSN or NICE or FIVN or TWLO?
By beta (market sensitivity over 5 years), Sangoma Technologies Corporation (SANG) is the lower-risk stock at 0.
16β versus LivePerson, Inc. 's 2. 05β — meaning LPSN is approximately 1211% more volatile than SANG relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 108% for Five9, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SANG or LPSN or NICE or FIVN or TWLO?
By revenue growth (latest reported year), Twilio Inc.
(TWLO) is pulling ahead at 13. 7% versus -22. 0% for LivePerson, Inc. (LPSN). On earnings-per-share growth, the picture is similar: Five9, Inc. grew EPS 370. 6% year-over-year, compared to 40. 5% for Sangoma Technologies Corporation. Over a 3-year CAGR, FIVN leads at 13. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SANG or LPSN or NICE or FIVN or TWLO?
NICE Ltd.
(NICE) is the more profitable company, earning 20. 8% net margin versus -27. 6% for LivePerson, Inc. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus -9. 6% for LPSN. At the gross margin level — before operating expenses — NICE leads at 66. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SANG or LPSN or NICE or FIVN or TWLO more undervalued right now?
On forward earnings alone, Five9, Inc.
(FIVN) trades at 7. 0x forward P/E versus 36. 3x for Twilio Inc. — 29. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NICE: 57. 8% to $150. 88.
08Which pays a better dividend — SANG or LPSN or NICE or FIVN or TWLO?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is SANG or LPSN or NICE or FIVN or TWLO better for a retirement portfolio?
For long-horizon retirement investors, Sangoma Technologies Corporation (SANG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
16), +1995% 10Y return). LivePerson, Inc. (LPSN) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SANG: +1995%, LPSN: -97. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SANG and LPSN and NICE and FIVN and TWLO?
These companies operate in different sectors (SANG (Technology) and LPSN (Technology) and NICE (Technology) and FIVN (Technology) and TWLO (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SANG is a small-cap quality compounder stock; LPSN is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; FIVN is a small-cap quality compounder stock; TWLO is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 9%
- Gross Margin > 29%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.